Agno Pharma Email Format

Pharmaceutical ManufacturingPennsylvania, United States51-200 Employees

Agno Pharma is a pharmaceutical manufacturing company and global CDMO that supplies critical RSMs, intermediates, active pharmaceutical ingredients (APIs) including highly potent and sterile APIs, as well as sterile drug product formulations to large and medium-sized pharmaceutical, biotech, generic, and CDMO customers. Founded in 2004, it operates process development and US-FDA inspected GMP-compliant manufacturing facilities with sterile suspension injectable capabilities and maintains a drug product formulation R&D laboratory for complex injectables. Headquartered in Bethlehem, Pennsylvania, Agno Pharma employs 51-200 people and offers a broad spectrum of services across the drug development and commercialization lifecycle, with a track record of delivering development and commercial-stage cGMP manufacturing solutions in North America and Europe. The company has expanded its US footprint through acquisitions and partnerships, including the 2023 acquisition of Lubrizol Particle Sciences, the 2026 acquisition of Actylis's Cascade Chemistry assets in Eugene, Oregon, and partnerships with SiCare Bio (2025) and Particlesciences (2026), along with an expansion of its US offices in 2026.

Sign up for free to view info

Company overview Employee directory